- Home
- TNGX vs KRNY Comparison
TNGX vs KRNY Comparison
Compare TNGX & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- KRNY
- Stock Information
- Founded
- TNGX 2014
- KRNY 1884
- Country
- TNGX United States
- KRNY United States
- Employees
- TNGX N/A
- KRNY N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- KRNY Savings Institutions
- Sector
- TNGX Health Care
- KRNY Finance
- Exchange
- TNGX Nasdaq
- KRNY Nasdaq
- Market Cap
- TNGX 351.2M
- KRNY 383.6M
- IPO Year
- TNGX N/A
- KRNY 2005
- Fundamental
- Price
- TNGX $5.16
- KRNY $6.08
- Analyst Decision
- TNGX Strong Buy
- KRNY Buy
- Analyst Count
- TNGX 6
- KRNY 2
- Target Price
- TNGX $12.20
- KRNY $7.75
- AVG Volume (30 Days)
- TNGX 3.9M
- KRNY 439.6K
- Earning Date
- TNGX 08-06-2025
- KRNY 07-24-2025
- Dividend Yield
- TNGX N/A
- KRNY 7.32%
- EPS Growth
- TNGX N/A
- KRNY N/A
- EPS
- TNGX N/A
- KRNY N/A
- Revenue
- TNGX $40,990,000.00
- KRNY $148,135,000.00
- Revenue This Year
- TNGX N/A
- KRNY $2.69
- Revenue Next Year
- TNGX N/A
- KRNY $24.18
- P/E Ratio
- TNGX N/A
- KRNY N/A
- Revenue Growth
- TNGX 10.09
- KRNY 3.61
- 52 Week Low
- TNGX $1.03
- KRNY $5.45
- 52 Week High
- TNGX $12.02
- KRNY $8.59
- Technical
- Relative Strength Index (RSI)
- TNGX 79.99
- KRNY 47.08
- Support Level
- TNGX $4.40
- KRNY $5.99
- Resistance Level
- TNGX $5.37
- KRNY $6.34
- Average True Range (ATR)
- TNGX 0.65
- KRNY 0.16
- MACD
- TNGX 0.10
- KRNY -0.00
- Stochastic Oscillator
- TNGX 93.68
- KRNY 43.40
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.